|
nystatin A1 |
0 |
0.74 |
0.63 |
0.76 |
1.0 |
Glyco:1/1 * 6-Ring:1/1 |
MIBiG |
Source |
C[C@@H]1OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@]2(O)C[C@H](O)[C@@H](C(=O)O)[C@H](C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)/C=C\C=C/C=C\C=C/CC/C=C\C=C/[C@H](C)[C@@H](O)[C@H]1C)O2 |
view |
nystatin A1 |
|
|
Amphotericin B |
1 |
0.73 |
0.58 |
0.77 |
1.0 |
Glyco:1/1 * 6-Ring:1/1 |
MIBiG |
Source |
CC1OC(O[C@H]2/C=C\C=C/C=C\C=C/C=C\C=C/C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@]3(O)C[C@H](O)[C@@H](C(=O)O)[C@H](C2)O3)C(O)C(N)C1O |
view |
Amphotericin B |
|
|
brasilinolide C |
2 |
0.65 |
0.48 |
0.69 |
1.0 |
Glyco:1/1 * 6-Ring:1/1 |
MIBiG |
Source |
C[C@@H]1O[C@@H](O[C@@H](C)[C@H](C)[C@H](O)[C@@H](C)[C@H](O)[C@H](C)[C@H]2OC(=O)/C=C\C[C@H](O)C[C@H](O)C[C@@H](O)CC[C@@H](C)[C@H](O)C[C@]3(O)O[C@H](C[C@@H](O)C[C@H](O)CCC[C@H](O)[C@@H]4O[C@H]4[C@@H]2C)C[C@H](O)[C@H]3O)C[C@H](O)[C@@H]1O |
view |
brasilinolide C |
|
|
rimocidin |
3 |
0.64 |
0.55 |
0.62 |
1.0 |
Glyco:1/1 * 6-Ring:1/1 |
MIBiG |
Source |
CCC[C@@H]1C/C=C\C=C/C=C\C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)CCCC(=O)C[C@@H](O)[C@H](CC)C(=O)O1)C[C@H](O)[C@H]2C(=O)O |
view |
rimocidin |
|
|
candicidin |
4 |
0.63 |
0.5 |
0.71 |
0.67 |
Glyco:1/1 * 6-Ring:0/1 |
MIBiG |
Source |
CC1/C=C\C=C/C=C\C=C/C=C\C=C/C=C\C(OC2OC(C)C(O)C(N)C2O)CC(O)C(C(=O)O)C(O)CC(=O)CC(O)CC(O)CC(O)CC(=O)CCCC(=O)CC(=O)OC1C(C)CC(C)C(O)CC(=O)c1ccc(N)cc1 |
view |
candicidin |
|
|
Sorangicin A |
5 |
0.62 |
0.51 |
0.74 |
0.5 |
Glyco:0/1 * 6-Ring:2/1 |
MIBiG |
Source |
C/C(=C\C(C)CCCCC(=O)O)[C@@H]1O[C@@H]2C=CC1OC(=O)/C=C\C=C/C=C\[C@H]1OC3C[C@@H]1O[C@@H](/C=C\CC1O[C@H](C[C@H](O)C1C)[C@@H](O)[C@@H](O)/C=C\CC/C=C\C2)C3C |
view |
Sorangicin A |
|
|
macrolactin 1b |
6 |
0.62 |
0.56 |
0.66 |
0.67 |
Glyco:1/1 * 6-Ring:0/1 |
MIBiG |
Source |
C[C@@H]1CCC/C=C\C=C/[C@H](O)C[C@@H](O)C/C=C\C=C/[C@@H](O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O)C/C=C\C=C/C(=O)O1 |
view |
macrolactin 1b |
|
|
macrolactin 1c |
7 |
0.62 |
0.56 |
0.66 |
0.67 |
Glyco:1/1 * 6-Ring:0/1 |
MIBiG |
Source |
CC1CCC/C=C\C=C/C(OC2OC(CO)C(O)C(O)C2O)CC(O)C/C=C\C=C/C(O)C/C=C\C=C/C(=O)O1 |
view |
macrolactin 1c |
|
|
kirromycin |
8 |
0.6 |
0.48 |
0.67 |
0.67 |
Glyco:0/1 * 6-Ring:1/1 |
MIBiG |
Source |
C/C=C\C=C\[C@@H]1O[C@](O)([C@H](CC)C(=O)NC/C=C/C=C(\C)[C@@H](OC)[C@@H](C)[C@@H]2O[C@H](/C=C/C=C/C=C(C)/C(O)=C3/C(=O)C=CNC3=O)[C@H](O)[C@@H]2O)[C@H](O)[C@H](O)C1(C)C |
view |
kirromycin |
|
|
ECO-02301 |
9 |
0.6 |
0.51 |
0.65 |
0.67 |
Glyco:1/1 * 6-Ring:0/1 |
MIBiG |
Source |
CC(/C=C/CC/C=C/C=C/C=C/C=C/C(=O)NC1=C(O)CCC1=O)C(O)C(C)C(O)/C=C/C=C/C=C/C=C/C=C/CC(O[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O)C(C)C(=O)CC(O)CC(O)CC(O)/C=C/CC(O)CC(O)CC(O)CC(O)/C=C/CC(O)CC(O)CCCN |
view |
ECO-02301 |
|
|
halstoctacosanolide |
10 |
0.6 |
0.54 |
0.62 |
0.67 |
Glyco:0/1 * 6-Ring:1/1 |
MIBiG |
Source |
CCC(O)C(C)C(O)CC(O)C(O)/C=C(\C)CC(C)C1CC(O)C(C)/C=C\C=C/CC(C)C(=O)CC2CCC(C)C(O)(C/C=C(C)\C=C(\C)C(O)C(=O)/C=C(/C)C(=O)O1)O2 |
view |
halstoctacosanolide |
|
|
filipin |
11 |
0.59 |
0.58 |
0.74 |
0.0 |
Glyco:0/1 * 6-Ring:0/1 |
MIBiG |
Source |
CCCCC[C@@H](O)[C@H]1C(=O)O[C@H](C)[C@@H](O)/C=C\C=C/C=C\C=C/C=C(/C)[C@@H](O)C[C@H](O)C[C@H](O)C[C@H](O)C[C@H](O)C[C@H](O)C[C@@H]1O |
view |
filipin |
|
|
meridamycin |
12 |
0.59 |
0.5 |
0.63 |
0.67 |
Glyco:0/1 * 6-Ring:1/1 |
MIBiG |
Source |
CC/C1=C/C[C@@H](/C(C)=C/[C@@H](C)[C@@H](C)O)OC(=O)C2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H](CC[C@H]2C)C[C@H](O)[C@H](C)[C@@H](O)C[C@@H](O)C[C@H](O)/C(C)=C\[C@@H](C)CC(C)[C@@H]1O |
view |
meridamycin |
|
|
pimaricin |
13 |
0.59 |
0.48 |
0.57 |
1.0 |
Glyco:1/1 * 6-Ring:1/1 |
MIBiG |
Source |
C[C@@H]1C/C=C\C=C/C=C\C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@H]3O[C@@H]3/C=C\C(=O)O1)C[C@H](O)[C@H]2C(=O)O |
view |
pimaricin |
|
|
Spirangien A1 |
14 |
0.57 |
0.52 |
0.63 |
0.5 |
Glyco:0/1 * 6-Ring:2/1 |
MIBiG |
Source |
C/C=C(\C)C[C@H](C)[C@H](O)[C@@H](C)[C@H]1O[C@@]2(C[C@@H](OC)[C@H]1C)O[C@H]([C@@H](C)[C@@H](O)[C@@H](C)/C=C\C=C\C=C/C=C/C=C\[C@H](CC(=O)O)OC)[C@@H](C)C[C@@H]2O |
view |
Spirangien A1 |
|
|
Etnangien |
15 |
0.56 |
0.63 |
0.65 |
0.0 |
Glyco:0/1 * 6-Ring:0/1 |
MIBiG |
Source |
COC1C(C)C(O)CC(=O)OC(C(C)C(O)/C=C(C)/C=C/C=C/C=C/C=C/C=C/CC(O)/C=C(\C)CCC(=O)O)CC(O)CCCC(O)C/C=C\C=C/CC(C)C(O)C1C |
view |
Etnangien |
|
|
macrolactin 1a |
16 |
0.55 |
0.53 |
0.71 |
0.0 |
Glyco:0/1 * 6-Ring:0/1 |
MIBiG |
Source |
C[C@@H]1CCC/C=C\C=C/[C@@H](O)C[C@@H](O)C/C=C\C=C/[C@H](O)C/C=C\C=C/C(=O)O1 |
view |
macrolactin 1a |
|
|
oligomycin |
17 |
0.55 |
0.47 |
0.63 |
0.5 |
Glyco:0/1 * 6-Ring:2/1 |
MIBiG |
Source |
CC[C@@H]1/C=C\C=C/C[C@H](C)[C@@H](O)[C@](C)(O)C(=O)[C@H](C)[C@@H](O)[C@H](C)C(=O)[C@H](C)[C@@H](O)[C@H](C)/C=C\C(=O)O[C@H]2[C@@H](C)[C@@H](CC1)O[C@@]1(CC[C@@H](C)[C@@H](C[C@H](C)O)O1)[C@@H]2C |
view |
oligomycin |
|
|
concanamycin A |
18 |
0.55 |
0.46 |
0.58 |
0.67 |
Glyco:0/1 * 6-Ring:1/1 |
MIBiG |
Source |
C/C=C/[C@H]1O[C@@](O)([C@@H](C)[C@H](O)[C@H](C)[C@H]2OC(=O)/C(OC)=C\C(C)=C/[C@@H](C)[C@@H](O)[C@@H](CC)[C@@H](O)[C@H](C)C/C(C)=C\C=C/[C@@H]2OC)C[C@@H](O)[C@@H]1C |
view |
concanamycin A |
|
|
macrolactin 3a |
19 |
0.54 |
0.51 |
0.7 |
0.0 |
Glyco:0/1 * 6-Ring:0/1 |
MIBiG |
Source |
C[C@@H]1CCC/C=C\C=C/C(=O)C[C@@H](O)C/C=C\C=C/[C@@H](O)C/C=C\C=C/C(=O)O1 |
view |
macrolactin 3a |
|
|
Onnamide A |
20 |
0.54 |
0.47 |
0.6 |
0.5 |
Glyco:0/1 * 6-Ring:2/1 |
MIBiG |
Source |
C=C1C[C@](OC)([C@H](O)C(=O)N[C@H]2OCO[C@H]3[C@@H]2O[C@H](C[C@H](O)CCC/C=C/C=C/C=C/C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)C(C)(C)[C@@H]3OC)O[C@H](C)[C@@H]1C |
view |
Onnamide A |
|
|
mycolactone |
21 |
0.53 |
0.49 |
0.7 |
0.0 |
Glyco:0/1 * 6-Ring:0/1 |
MIBiG |
Source |
C/C1=C/C[C@H]([C@@H](C)C/C(C)=C/[C@@H](C)[C@H](O)C[C@@H](C)O)OC(=O)CCC[C@H](OC(=O)/C=C/C(C)=C/C(C)=C/C=C/C(C)=C/[C@H](O)[C@@H](O)C[C@H](C)O)[C@@H](C)C1 |
view |
mycolactone |
|
|
JBIR-100 |
22 |
0.53 |
0.46 |
0.54 |
0.67 |
Glyco:0/1 * 6-Ring:1/1 |
MIBiG |
Source |
C/C1=C/C(C)C(O)C(C)C/C(C)=C\C=C/CC(C(C)C(O)C(C)C2(O)CC(OC(=O)/C=C/C(=O)O)C(C)C(C(C)C)O2)OC(=O)\C(C)=C/1 |
view |
JBIR-100 |
|
|
reveromycin |
23 |
0.52 |
0.46 |
0.56 |
0.5 |
Glyco:0/1 * 6-Ring:2/1 |
MIBiG |
Source |
CCCC[C@@]1(OC(=O)CCC(=O)O)CC[C@]2(CC[C@H](C)[C@@H](C/C=C(C)/C=C/[C@H](O)C(C)/C=C/C(=O)O)O2)O[C@H]1/C=C/C(C)=C/C(=O)O |
view |
reveromycin |
|
|
alpha-lipomycin |
24 |
0.52 |
0.46 |
0.52 |
0.67 |
Glyco:1/1 * 6-Ring:0/1 |
MIBiG |
Source |
CC(/C=C/C=C/C=C/C=C/C(=O)C1=C(O)C(CCC(=O)O)N(C)C1=O)=C\C(C)C(O[C@H]1C[C@H](O)[C@H](O)[C@@H](C)O1)C(C)C |
view |
alpha-lipomycin |
|
|
bacillaene |
45 |
0.45 |
0.51 |
0.52 |
0.0 |
Glyco:0/1 * 6-Ring:0/1 |
MIBiG |
Source |
C/C(=C/C=C/C=C/C(C)C(=O)O)NC(=O)CC(O)/C(C)=C\C=C/C=C(C)/C=C/C=C\CCCNC(=O)C(O)CC(C)C |
view |
bacillaene |
|
|
thailandamide B |
25 |
0.5 |
0.47 |
0.64 |
0.0 |
Glyco:0/1 * 6-Ring:0/1 |
MIBiG |
Source |
CO[C@H](/C(C)=C/C=C/C=C(C)/C=C/C[C@H](O)CC(=O)/C=C\C=C(C)\C=C\[C@@H](C)NC(=O)[C@H](C)C/C=C/C[C@@H](O)Cc1ccc(O)cc1)[C@@H](C)C(=O)O |
view |
thailandamide B |
|
|
thailandamide A |
26 |
0.5 |
0.47 |
0.64 |
0.0 |
Glyco:0/1 * 6-Ring:0/1 |
MIBiG |
Source |
CO[C@H](/C(C)=C/C=C/C=C(C)/C=C/C[C@H](O)CC(=O)/C=C/C=C(C)/C=C/[C@@H](C)NC(=O)[C@H](C)C/C=C/C[C@@H](O)Cc1ccc(O)cc1)[C@@H](C)C(=O)O |
view |
thailandamide A |
|
|
heronamide A |
27 |
0.49 |
0.48 |
0.62 |
0.0 |
Glyco:0/1 * 6-Ring:0/1 |
MIBiG |
Source |
CCC/C=C/C=C/C[C@@H]1C[C@H](O)C2[C@@H]3/C(C)=C\[C@@H]4C=C[C@H](O)[C@H](O)[C@H]4/C(C)=C\C=C/[C@H]3C(=O)N21 |
view |
heronamide A |
|
|
macrobrevin |
28 |
0.49 |
0.53 |
0.59 |
0.0 |
Glyco:0/1 * 6-Ring:0/1 |
MIBiG |
Source |
CCC(C)C(O)/C=C/C(C)=C/C=C/C(C)CC(C)C1CC(O)C(C)/C=C\C=C/C(C)C/C=C(/C)C(O)/C=C\CC(O)C(C)/C=C\C(=O)O1 |
view |
macrobrevin |
|
|
enacyloxin |
29 |
0.48 |
0.48 |
0.61 |
0.0 |
Glyco:0/1 * 6-Ring:0/1 |
MIBiG |
Source |
CC/C=C/[C@@H](OC(N)=O)[C@@H](Cl)[C@H](O)CC(=O)C(O)C(O)[C@H](C)/C(Cl)=C/C=C/C=C(C)/C=C/C=C/C(=O)O[C@@H]1C[C@@H](C(=O)O)CC[C@@H]1O |
view |
enacyloxin |
|
|
isobongkrekic acid |
30 |
0.48 |
0.5 |
0.59 |
0.0 |
Glyco:0/1 * 6-Ring:0/1 |
MIBiG |
Source |
CO[C@H](C/C=C\C=C\CC/C=C/C[C@H](C)/C=C/C(=C/C(=O)O)CC(=O)O)/C(C)=C\C=C(C)C |
view |
isobongkrekic acid |
|
|
FD-891 |
31 |
0.48 |
0.5 |
0.58 |
0.0 |
Glyco:0/1 * 6-Ring:0/1 |
MIBiG |
Source |
CO[C@@H](C)[C@@H](C)[C@H](O)[C@H](C)[C@@H](O)CCC(C)[C@@H]1C/C=C\C=C/CC(O)C2O[C@H]2[C@@H](O)[C@H](C)/C=C(C)\C=C(\C)C(=O)O1 |
view |
FD-891 |
|
|
Thuggacin A |
32 |
0.47 |
0.46 |
0.6 |
0.0 |
Glyco:0/1 * 6-Ring:0/1 |
MIBiG |
Source |
C/C=C(C)/C=C(\C)C(O)C(C)[C@@H](O)[C@H](O)[C@@H]1C/C=C\C=C/[C@@H](O)C[C@H](O)[C@@H](C)c2nc(cs2)/C=C(/CCCCCC)C(=O)O1 |
view |
Thuggacin A |
|
|
difficidin |
33 |
0.47 |
0.49 |
0.58 |
0.0 |
Glyco:0/1 * 6-Ring:0/1 |
MIBiG |
Source |
C=C/C=C(\C)CCC1C/C=C\C=C(\C)C(OP(=O)(O)O)CCC/C=C\C=C/C=C\CC(C)C(=C)CC(=O)O1 |
view |
difficidin |
|
|
bongkrekic acid |
34 |
0.47 |
0.49 |
0.58 |
0.0 |
Glyco:0/1 * 6-Ring:0/1 |
MIBiG |
Source |
COC(C/C=C\C=C\CC/C=C/CC(C)/C=C/C(=C\C(=O)O)CC(=O)O)/C(C)=C\C=C(/C)C(=O)O |
view |
bongkrekic acid |
|
|
heronamide B |
35 |
0.47 |
0.47 |
0.58 |
0.0 |
Glyco:0/1 * 6-Ring:0/1 |
MIBiG |
Source |
CCC/C=C/C=C/C[C@@H]1C[C@@H]2/C=C\C(C)=C/[C@@H]3C=C[C@H](O)[C@H](O)[C@H]3/C(C)=C\C=C/[C@H]2C(=O)N1 |
view |
heronamide B |
|
|
E-492 |
36 |
0.46 |
0.45 |
0.59 |
0.0 |
Glyco:0/1 * 6-Ring:0/1 |
MIBiG |
Source |
C/C=C(\C)C(O)C(C)/C=C/C=C/CCC(O)CC1=C(C)C(=O)C(O)(C(C)O)O1 |
view |
E-492 |
|
|
Lactimidomycin |
37 |
0.46 |
0.45 |
0.58 |
0.0 |
Glyco:0/1 * 6-Ring:0/1 |
MIBiG |
Source |
C/C(=C\[C@H](C)C(=O)C[C@H](O)CC1CC(=O)NC(=O)C1)[C@@H]1OC(=O)/C=C\CC/C=C\C=C/[C@@H]1C |
view |
Lactimidomycin |
|
|
Kalimantacin A |
38 |
0.46 |
0.46 |
0.57 |
0.0 |
Glyco:0/1 * 6-Ring:0/1 |
MIBiG |
Source |
C=C(CCC=CC=CCC(C)CC(=O)CC(O)CNC(=O)C(C)C(C)OC(N)=O)CC(C)CC(C)=CC(=O)O |
view |
Kalimantacin A |
|
|
ansatrienin (mycotrienin) |
39 |
0.45 |
0.46 |
0.56 |
0.0 |
Glyco:0/1 * 6-Ring:0/1 |
MIBiG |
Source |
COC1/C=C\C=C/C=C\CC(OC(=O)[C@@H](C)NC(=O)C2CCCCC2)C(C)C(O)/C(C)=C\CCC2=CC(=O)C=C(NC(=O)C1)C2=O |
view |
ansatrienin (mycotrienin) |
|
|
naphthomycin |
40 |
0.45 |
0.46 |
0.56 |
0.0 |
Glyco:0/1 * 6-Ring:0/1 |
MIBiG |
Source |
C/C1=C/C[C@H](O)/C=C\[C@H](C)[C@H](O)[C@@H](C)/C=C(/C)C(=O)c2c(O)c(C)cc3c2C(=O)C(Cl)=C(NC(=O)/C(C)=C\C=C/C=C\[C@H](C)[C@@H](O)CC1=O)C3=O |
view |
naphthomycin |
|
|
Elansolid A1 |
41 |
0.45 |
0.47 |
0.55 |
0.0 |
Glyco:0/1 * 6-Ring:0/1 |
MIBiG |
Source |
COC(c1ccc(O)cc1)C1C(/C=C\C=C\C=C/C(O)C(C)C(O)C/C=C(C)/C=C/C(=O)O)C(C)=CC2C1C(C)(C)C[C@]2(C)O |
view |
Elansolid A1 |
|
|
13-epi-Dorrigocin A |
42 |
0.45 |
0.46 |
0.55 |
0.0 |
Glyco:0/1 * 6-Ring:0/1 |
MIBiG |
Source |
CO[C@@H](/C=C/CC/C=C/C(=O)O)[C@@H](O)[C@H](C)/C=C(\C)[C@@H](O)[C@H](C)C(=O)CCCC1CC(=O)NC(=O)C1 |
view |
13-epi-Dorrigocin A |
|
|
Dorrigocin A |
43 |
0.45 |
0.46 |
0.55 |
0.0 |
Glyco:0/1 * 6-Ring:0/1 |
MIBiG |
Source |
CO[C@@H](/C=C/CC/C=C/C(=O)O)[C@@H](O)[C@H](C)/C=C(\C)[C@H](O)[C@H](C)C(=O)CCCC1CC(=O)NC(=O)C1 |
view |
Dorrigocin A |
|
|
Dorrigocin B |
44 |
0.45 |
0.46 |
0.55 |
0.0 |
Glyco:0/1 * 6-Ring:0/1 |
MIBiG |
Source |
CO[C@@H](/C=C/CC/C=C/C(=O)O)[C@@H](O)[C@H](C)[C@@H](O)/C(C)=C/[C@H](C)C(=O)CCCC1CC(=O)NC(=O)C1 |
view |
Dorrigocin B |
|
|
heronamide C |
46 |
0.44 |
0.48 |
0.53 |
0.0 |
Glyco:0/1 * 6-Ring:0/1 |
MIBiG |
Source |
CCC/C=C\C=C/C[C@H]1C/C=C\C=C(C)/C=C\C=C/[C@H](O)[C@H](O)/C=C(C)\C=C/C=C\C(=O)N1 |
view |
heronamide C |
|
|
BE-14106 |
47 |
0.43 |
0.45 |
0.53 |
0.0 |
Glyco:0/1 * 6-Ring:0/1 |
MIBiG |
Source |
CCC/C=C/CC1C/C=C\C=C(C)/C=C\C=C/C(O)C(O)/C=C(C)\C=C/C=C\C(=O)N1 |
view |
BE-14106 |
|
|
E-975 |
48 |
0.43 |
0.46 |
0.52 |
0.0 |
Glyco:0/1 * 6-Ring:0/1 |
MIBiG |
Source |
CC/C=C(\C)C(O)C(C)/C=C/C=C/CCC(O)CC1=C(C)C(=O)C(O)(C(C)O)O1 |
view |
E-975 |
|
|
fumonisin |
49 |
0.4 |
0.46 |
0.46 |
0.0 |
Glyco:0/1 * 6-Ring:0/1 |
MIBiG |
Source |
CCCCC(C)C(OC(=O)CC(CC(=O)O)C(=O)O)C(CC(C)CC(O)CCCCC(O)CC(O)C(C)N)OC(=O)CC(CC(=O)O)C(=O)O |
view |
fumonisin |
|